Chronic Kidney Disease

SGLT2 inhibitors were associated with similar renal and CV outcomes vs. GLP-1 receptor agonists for patients with diabetes, regardless of chronic kidney disease status, researchers reported.

In an analysis of more than 3 million U.S. adults, most patients with a class 1a recommendation for SGLT2 inhibitors were not prescribed them, researchers reported in the Journal of the American College of Cardiology.

Adults with type 2 diabetes have lower risks for death and major adverse cardiovascular and kidney events if they use tirzepatide compared with GLP-1 receptor agonists, according to observational data published in JAMA Network Open.

Managing patients with an illness like chronic kidney disease can be difficult at times for caregivers, but Michelle Rowlett, MSW, LICSW, knows that for patients grappling with a disease that can last a lifetime, it poses many challenges.

Metformin may protect against the progression of adverse renal and cardiovascular outcomes in patients systemic lupus erythematosus, including lupus nephritis and infarction, according to data published in ACR Open Rheumatology.

Hyperkalemia may be considered a common occurrence in patients with chronic kidney disease, particularly in those with heart failure or diabetes, published data show.

Incident cardiovascular and thromboembolic events may be more closely linked to the severity of kidney disease than with glomerular disease subtype, according to results of a prospective study.

Slowing the progression to advanced diabetic kidney disease could lower the economic impact of the condition and help health care systems optimize resources, recently published data show.

In October 2023, the American Heart Association unveiled the term cardiovascular-kidney-metabolic syndrome to reflect the connection between metabolic and renal conditions associated with risk for heart disease.

Children with presymptomatic type 1 diabetes who had COVID-19 experienced higher rates of type 1 diabetes diagnoses than those who did not have COVID-19, according to recently published data.